Introduction:The purpose of this study is to evaluate patient, tumor, and technical factors associated with procedural complications and non-diagnostic findings following percutaneous core renal mass biopsyMethods:Core renal mass biopsies from 2000-2017 were reviewed. Complications ≤30 days were graded using the Clavien-Dindo system. Univariate and multivariable analyses were used to evaluate associations between clinical characteristics and risk of complications or non-diagnostic findings.Results:Of 1155 biopsies, procedural complications were identified in 24 (2.2%) patients including 5 (0.4%) patients with major complications (≥Clavien 3a). There were no patients with tumor seeding of biopsy tract identified.Age, body mass index (BMI), gender, Charlson comorbidity index, smoking, diameter, nephrometry score, number of cores, and prior biopsy were not associated with complication risk, p=0.06-0.53. Complications were not increased for patients on ASA, low platelets (25,000-160,000), or mildly el...